Interpretation Of The Prostate Cancer Prevention Trial

... UroToday.com - The Prostate Cancer Prevention Trial (PCPT) was designed to determine if the biopsy proven prevalence of prostate cancer (CaP) was less in a group of men taking finasteride vs. placebo. The 7-year trial demonstrated a 24.8% reduction in the finasteride group, but the finasteride patients who were diagnosed with CaP were more likely to have high-grade disease (6. [click link for full article] ...